Managing Metformin-Associated Lactic Acidosis with Continuous Renal Replacement Therapy
Author Information
Author(s): Geoffray Keller, Martin Cour, Romain Hernu, Julien Illinger, Dominique Robert, Laurent Argaud
Primary Institution: Hospices Civils de Lyon, Groupement Hospitalier Edouard Herriot, Service de Réanimation Médicale, Lyon, France
Hypothesis
Can continuous renal replacement therapy (CRRT) effectively manage metformin-associated lactic acidosis (MALA) in patients with hemodynamic instability?
Conclusion
CRRT efficiently treated MALA in all six patients, leading to favorable outcomes.
Supporting Evidence
- All patients had severe lactic acidosis with high illness severity scores.
- CRRT was well tolerated with no complications reported.
- Metabolic acidosis and metformin levels were rapidly controlled within 24 hours.
Takeaway
Doctors found that a special treatment called CRRT helped patients with a serious problem caused by a diabetes medicine called metformin.
Methodology
The study retrospectively analyzed six patients with severe lactic acidosis due to metformin, treated with CRRT in an ICU over three years.
Potential Biases
Potential biases may arise from the retrospective nature of the study and selection criteria.
Limitations
The study is limited by its small sample size and retrospective design.
Participant Demographics
One male and five female patients, with a mean age of 69 years.
Statistical Information
P-Value
p<0.01
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website